Portwine stainhttps://en.wikipedia.org/wiki/Port-wine_stain
Portwine stain bụ ngbanwe nke akpụkpọ ahụ mmadụ nke mmebi nke capillary na akpụkpọ ahụ kpatara. A na-akpọ ha aha maka agba agba ha, nke yiri ka mmanya ọdụ ụgbọ mmiri, mmanya na-acha uhie uhie si Portugal. Portwine stain bụ ihe na-adịghị mma nke capillary, nke a na-ahụ mgbe a mụrụ ya. Portwine stain na-adịgide ndụ niile. Mpaghara akpụkpọ ahụ emetụtara na-eto n'ụzọ kwesịrị ekwesị na uto n'ozuzu ya.

Portwine stain na-emekarị n'ihu mana ọ nwere ike ịpụta n'ebe ọ bụla na ahụ, karịsịa n'olu, ogwe elu, ogwe aka na ụkwụ. Ntụpọ mbụ na-adịkarị larịị yana pink n'ọdịdị. Ka nwatakịrị ahụ na-etolite, ụcha ya nwere ike ịba n'ime na-acha uhie uhie ma ọ bụ na-acha odo odo. N'oge dimkpa, ọnya ahụ ma ọ bụ mmepe nke obere lumps nwere ike ime.

Ọgwụgwọ
Laser Vascular dị ntakịrị irè, mana chọrọ akụrụngwa laser dị oke ọnụ yana ọgwụgwọ ogologo oge karịa ọtụtụ afọ. Ka ọnya na-eto eto na-eto eto, ọgwụgwọ laser nwere ike ghara ịdị irè, nke nwere ike ịbụ nsogbu. Ọnya pink na-esikarị ike ịgwọta karịa ọnya ọbara ọbara n'ihi na ha na-enwe mmetụta miri emi.
#Dye laser (e.g. V-beam)
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
  • Enwere ike iji laser gwọọ Portwine stain, mana ọ dị oke ọnụ ma na-ewe oge.
    References A retrospective 10 years‐ experience overview of dye laser treatments for vascular pathologies 37632184 
    NIH
    A na-amata Flash-lamp pulsed dye laser (FPDL) ugbu a dị ka laser kachasị dị maka ịgwọ nsogbu vaskụla elu-elu. N'ime ọmụmụ ihe a, anyị chịkọtara data na-agafe afọ iri nke ahụmahụ site na iji ọgwụgwọ laser agba agba maka ndị ọrịa nwere ọnọdụ vaskụla dị iche iche (telangiectasia, rhinophyma, port-wine stains, cherry and spider angiomas, and vascular tumors such as cherry angiomas, infantile hemangiomas, port wine stains, rhinophyma, spider angiomas, and telangiectasia) .
    The Flash‐lamp pulsed dye laser (FPDL) is nowadays considered the most precise laser currently on the market for treating superficial vascular lesions. In this study, we gathered data from 10 years of experience regarding dye laser treatment of patients presenting vascular malformations such as telangiectasia, rhinophyma, port‐wine stain, cherry and spider angioma and vascular tumours: cherry angioma, infantile haemangioma, port wine stain, rhinophyma, spider angioma, telangiectasia
     Nevus Flammeus 33085401 
    NIH
    A na-akpọkwa Port-wine stain (PWS) dị ka nevus flammeus. Ọ bụ akwa pink ma ọ bụ ọbara ọbara n'akpụkpọ ahụ nwa ọhụrụ nke arịa ọbara na-adịghị mma kpatara ya. Ọ na-adị mgbe a mụrụ ya, ọ na-adịkwa ndụ, na-apụtakarị n'ihu. Ọ dị mkpa ịmata ọdịiche dị na ya na nevus simplex ma ọ bụ salmon patch, nke na-apụ n'anya ka oge na-aga.
    Nevus flammeus or port-wine stain (PWS) is a non-neoplastic congenital dermal capillary hamartomatous malformation presenting as a pink or red patch on a newborn's skin. It is a congenital skin condition that can affect any part of the body and persists throughout life. The nevus flammeus is a well-defined, often unilateral, bilateral, or centrally positioned pink to red patch that appears on the face at birth and is made up of distorted capillary-like vessels. It needs to be differentiated from a nevus simplex/salmon patch, which is usually seen along the midline and disappears over time. An acquired port-wine stain, clinically and histopathologically indistinguishable from congenital capillary malformation, has been reported to develop in adolescents or adults, usually following trauma.
     Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber syndrome 33175124 
    NIH
    Ịgwọ PWS dị mkpa iji belata mmetụta ya na ahụike uche yana ibelata nodularity na mmụba anụ ahụ. Ịmalite ọgwụgwọ n'oge nwere ike ibute nsonaazụ ka mma. A na-ewere Pulsed dye laser (PDL) dị ka nhọrọ kacha mma maka ụdị PWS niile, n'agbanyeghị nha ha, ebe ha nọ, ma ọ bụ agba ha.
    Treatment of PWB is indicated to minimize psychosocial impact and diminish nodularity, and potentially tissue hypertrophy. Better outcomes may be attained if treatments are started at an earlier age. In the United States, pulsed dye laser (PDL) is the gold standard for all PWB regardless of the lesion size, location, or color. When performed by experienced physicians, laser treatment can be performed safely on patients of all ages. The choice of using general anesthesia in young patients is a complex decision which must be considered on a case by case basis.